Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine vs Increased Dose of Angiotensin II Antagonist in Hypertensive Patients With Type 2 Diabetes
NCT00144144Phase 4Unknown
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amlodipine in hypertension (HTN) (2 arms). Primary endpoints: Changes in blood pressure level at home after getting up, Rate of blood pressure levels at home after getting up reaching target levels and 2 more. Status: unknown.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00144144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144144.